Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Selution SLR Drug-Eluting Balloon Gets FDA Nod for Coronary In-Stent Restenosis

(MedPage Today) -- The FDA approved the Selution sustained limus release (SLR) drug-eluting balloon (DEB or DCB) to treat coronary in-stent restenosis (ISR), Cordis announced Monday. This makes Selution SLR the only sirolimus-based DEB available...

Selution SLR Drug-Eluting Balloon Gets FDA Nod for Coronary In-Stent Restenosis

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Monday 21 September →